Julia Stowe

Summary

Affiliation: Health Protection Agency
Country: UK

Publications

  1. doi request reprint Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study
    Julia Stowe
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
    Vaccine 29:9467-72. 2011
  2. doi request reprint No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine
    Julia Stowe
    Immunisation Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    Vaccine 27:1422-5. 2009
  3. doi request reprint Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database
    Julia Stowe
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Am J Epidemiol 169:382-8. 2009
  4. doi request reprint A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark
    Nick Andrews
    Statistics Modelling and Economics Department, Health Protection Services, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
    Vaccine 30:3042-6. 2012
  5. doi request reprint Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series
    Nick Andrews
    Statistics Modelling and Economics Department, Health Protection Services, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
    Vaccine 29:7878-82. 2011
  6. pmc No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome
    Brent Taylor
    General and Adolescent Paediatric Unit, Institute of Child Health, University College London, London, UK
    Arch Dis Child 92:887-9. 2007
  7. ncbi request reprint Bell's palsy and parenteral inactivated influenza vaccine
    Julia Stowe
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Hum Vaccin 2:110-2. 2006
  8. doi request reprint Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis
    Elizabeth Miller
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, Colindale, London NW9 5EQ, UK
    BMJ 346:f794. 2013
  9. doi request reprint The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Services, Colindale, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    J Infect 65:17-24. 2012
  10. ncbi request reprint Post-licensure safety of the meningococcal group C conjugate vaccine
    Nick Andrews
    Statistics Unit, Health Protection Agency, Centre for Infections, London, UK
    Hum Vaccin 3:59-63. 2007

Detail Information

Publications13

  1. doi request reprint Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study
    Julia Stowe
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, London, United Kingdom
    Vaccine 29:9467-72. 2011
    ..These results neither provide evidence of an increased risk of convulsions following TIV over a 10-year surveillance period nor following a single dose of the ASO3 adjuvanted monovalent H1N1 vaccine in 2009/10...
  2. doi request reprint No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine
    Julia Stowe
    Immunisation Department, Health Protection Agency Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    Vaccine 27:1422-5. 2009
    ....
  3. doi request reprint Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database
    Julia Stowe
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Am J Epidemiol 169:382-8. 2009
    ....
  4. doi request reprint A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark
    Nick Andrews
    Statistics Modelling and Economics Department, Health Protection Services, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
    Vaccine 30:3042-6. 2012
    ..The study therefore shows the potential for vaccine safety collaborations across Europe to detect true associations through use of common protocols and sharing of results or data...
  5. doi request reprint Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series
    Nick Andrews
    Statistics Modelling and Economics Department, Health Protection Services, Health Protection Agency, Colindale, London NW9 5EQ, United Kingdom
    Vaccine 29:7878-82. 2011
    ..05 [95% confidence interval (CI) 0.37 to 2.24]). We found no evidence of an increased risk of GBS in the 6 weeks following pandemic influenza vaccination...
  6. pmc No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome
    Brent Taylor
    General and Adolescent Paediatric Unit, Institute of Child Health, University College London, London, UK
    Arch Dis Child 92:887-9. 2007
    ..To investigate whether meningococcal C conjugate vaccine (MCCV) caused relapse in children with steroid-responsive nephrotic syndrome...
  7. ncbi request reprint Bell's palsy and parenteral inactivated influenza vaccine
    Julia Stowe
    Immunisation Department, Health Protection Agency Centre for Infections, London, UK
    Hum Vaccin 2:110-2. 2006
    ..78-1.08). There was also no evidence of an increased risk in any age group or following pneumococcal vaccine. A significant increase was seen on the day of vaccination (day 0) probably due to opportunistic recording of cases...
  8. doi request reprint Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis
    Elizabeth Miller
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Agency, Colindale, London NW9 5EQ, UK
    BMJ 346:f794. 2013
    ..To evaluate the risk of narcolepsy in children and adolescents in England targeted for vaccination with ASO3 adjuvanted pandemic A/H1N1 2009 vaccine (Pandemrix) from October 2009...
  9. doi request reprint The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England
    Albert Jan van Hoek
    Immunisation, Hepatitis and Blood Safety Department, Health Protection Services, Colindale, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    J Infect 65:17-24. 2012
    ..Three years of post 7-valent pneumococcal conjugate vaccine (PCV7) data was included to investigate the herd protection effects...
  10. ncbi request reprint Post-licensure safety of the meningococcal group C conjugate vaccine
    Nick Andrews
    Statistics Unit, Health Protection Agency, Centre for Infections, London, UK
    Hum Vaccin 3:59-63. 2007
    ..15 (0.80-1.67). There was evidence of an increased risk of convulsions and idiopathic thrombocytopenic purpura following MMR vaccination as previously documented...
  11. doi request reprint The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales
    Mark Jit
    Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 6BT, United Kingdom
    Vaccine 29:115-22. 2010
    ..Key sources of uncertainty are the cost of vaccine delivery and the quality of life detriment due to a clinically apparent episode of confirmed influenza. The cost of vaccine purchase itself is relatively low...
  12. doi request reprint Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom
    Nick Andrews
    Statistics Unit, Health Protection Agency, Centre for Infections, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
    Vaccine 28:7215-20. 2010
    ..Although there were no other significant differences between vaccines the relative incidence was significantly above one on the day of vaccination for convulsions following DTwP/Hib and for apnoea/collapse following DTaP(5)/Hib/IPV...
  13. ncbi request reprint Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association
    Nick Andrews
    Statistics Unit, Health Protection Agency, Communicable Disease Surveillance Centre, London, United Kingdom
    Pediatrics 114:584-91. 2004
    ....